Painazol Pain Relief

Manufacturer
Hello Life, Inc. | Cosmetic Specialty Labs, Inc.
Effective date
2018-12-26
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:38:45

Label at a glance#

ProductPainazol Pain Relief
Active ingredientACONITUM NAPELLUS, ACTAEA SPICATA ROOT, HORSE CHESTNUT, BLACK COHOSH, PSEUDOGNAPHALIUM OBTUSIFOLIUM, LILIUM LANCIFOLIUM WHOLE FLOWERING, SOLANUM LYCOPERSICUM, OXALIC ACID DIHYDRATE, ARNICA MONTANA, BELLIS PERENNIS, BRYONIA ALBA ROOT, SALICYLIC ACID, CITRULLUS COLOCYNTHIS FRUIT PULP, IRIS VERSICOLOR ROOT, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, RUTA GRAVEOLENS FLOWERING TOP, STELLARIA MEDIA, HYPERICUM PERFORATUM
Label structure10 sections

Indications and uses

 to temporarily relieve symptoms commonly associated with minor aches, such as:   •    pain             •    bruising •    swelling •    stiffness •    tingling

Dosage and administration

Apply Painazol Gel directly to affected area, 2-6 times daily, or, as needed. Safe for ages 2 and up.

Storage and handling

•    store in a cool, dry place •    product must not come in contact with metal •    do not store next to electrical devices or appliances

Label contents#

Full prescribing information#

Active Ingredients (per dose)

OTC - ACTIVE INGREDIENT SECTION

Aconitum nap 5X, Actaea 5X, Aesculus
hipp 5X, Cimicifuga 5X, Gnaphalium
poly 5X, Lilium 5X, Lycopersicum 5X,
Oxalicum ac 6X HPUS
Arnica 5X, Bellis 5X HPUS
Bryonia 5X, Salicylicum ac 5X HPUS
Colocynthis 5X, Iris vers 5X, Mag
phos 8X, Ruta 5X, Stellaria med 5X HPUS
Hypericum 5X HPUS

Purpose

OTC - PURPOSE SECTION

Aconitum nap 5X, Actaea 5X, Aesculus
hipp 5X, Cimicifuga 5X, Gnaphalium
poly 5X, Lilium 5X, Lycopersicum 5X,
Oxalicum ac 6X HPUS……………………………..…Pain
Arnica 5X, Bellis 5X HPUS……….……………….....Bruised
Bryonia 5X, Salicylicum ac 5X HPUS………….......Swelling
Colocynthis 5X, Iris vers 5X, Mag
phos 8X, Ruta 5X, Stellaria med 5X HPUS….........Stiffness
Hypericum 5X HPUS……………………………….....Tingling


The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. Product indications are based on Homeopathic Materia Medica.

Uses

INDICATIONS & USAGE SECTION

 to temporarily relieve symptoms commonly associated with minor aches, such as:  
•    pain            
•    bruising
•    swelling
•    stiffness
•    tingling

Warnings

WARNINGS SECTION

Stop use and ask a doctor

OTC - STOP USE SECTION

if symptoms persist or worsen.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION



ask a health professional before use.


OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

WARNINGS AND PRECAUTIONS SECTION

For external use only



Use only as directed

OTHER SAFETY INFORMATION

DO NOT USE IF TAMPER SEAL IS BROKEN

FOR EXTERNAL USE ONLY

Directions

DOSAGE & ADMINISTRATION SECTION

Apply Painazol Gel directly to affected area, 2-6 times daily, or, as needed. Safe for ages 2 and up.

Other information

STORAGE AND HANDLING SECTION


•    store in a cool, dry place
•    product must not come in contact with metal
•    do not store next to electrical devices or appliances

Inactive ingredients

INACTIVE INGREDIENT SECTION

carbomer, glycerin, methylparaben, purified ionized mineral water, sodium hydroxide

Questions or comments?

OTC - QUESTIONS SECTION

You can email us at info@hellolife.net or call us toll-free at
 1.800.875.0850. Monday through Friday, 9am-5pm ET.

www.hellolife.net

DESCRIPTION SECTION

Mftd for: HelloLife, LLC
4460 44th St SE Ste. C-600
Grand Rapids, MI 49512
FDA Pharmaceutical Establishment #3009727070


Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49726-035-02

PAINAZOL™
Pain Relief Gel

•    FAST ACTING           
•    LONG LASTING
•    ODORLESS
•    COLORLESS

Homeopathic (OTC) Medicine
2.0 oz (56.7 g)
Painazol Pain Relief Gel label
Painazol Pain Relief Gel label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49726-035-022021-07-23C16284748780-1c7ccaba7-1965-fd44-e053-dadaa90aa01bDrug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACONITUM NAPELLUSACTIVE INGREDIENTU0NQ8555JD1
ACTAEA SPICATA ROOTACTIVE INGREDIENT3FU86L9OS01
ARNICA MONTANAACTIVE INGREDIENTO80TY208ZW1
BELLIS PERENNISACTIVE INGREDIENT2HU33I03UY1
BLACK COHOSHACTIVE INGREDIENTK73E24S6X91
BRYONIA ALBA ROOTACTIVE INGREDIENTT7J046YI2B1
CITRULLUS COLOCYNTHIS FRUIT PULPACTIVE INGREDIENT23H32AOH171
HORSE CHESTNUTACTIVE INGREDIENT3C18L6RJAZ1
HYPERICUM PERFORATUMACTIVE INGREDIENTXK4IUX8MNB1
IRIS VERSICOLOR ROOTACTIVE INGREDIENTX43D4L3DQC1
LILIUM LANCIFOLIUM WHOLE FLOWERINGACTIVE INGREDIENTX67Z2963PI1
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATEACTIVE INGREDIENTHF539G9L3Q1
OXALIC ACID DIHYDRATEACTIVE INGREDIENT0K2L2IJ59O1
PSEUDOGNAPHALIUM OBTUSIFOLIUMACTIVE INGREDIENT36XQ854NWW1
RUTA GRAVEOLENS FLOWERING TOPACTIVE INGREDIENTN94C2U587S1
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZ1
SOLANUM LYCOPERSICUMACTIVE INGREDIENT0243Q4990L1
STELLARIA MEDIAACTIVE INGREDIENT2H03479QVR1
ACONITUM NAPELLUSACTIVE MOIETYU0NQ8555JD1
ACTAEA SPICATA ROOTACTIVE MOIETY3FU86L9OS01
ARNICA MONTANAACTIVE MOIETYO80TY208ZW1
BELLIS PERENNISACTIVE MOIETY2HU33I03UY1
BLACK COHOSHACTIVE MOIETYK73E24S6X91
BRYONIA ALBA ROOTACTIVE MOIETYT7J046YI2B1
CITRULLUS COLOCYNTHIS FRUIT PULPACTIVE MOIETY23H32AOH171
HORSE CHESTNUTACTIVE MOIETY3C18L6RJAZ1
HYPERICUM PERFORATUMACTIVE MOIETYXK4IUX8MNB1
IRIS VERSICOLOR ROOTACTIVE MOIETYX43D4L3DQC1
LILIUM LANCIFOLIUM WHOLE FLOWERINGACTIVE MOIETYX67Z2963PI1
MAGNESIUM CATIONACTIVE MOIETYT6V3LHY8381
OXALIC ACIDACTIVE MOIETY9E7R5L6H311
PSEUDOGNAPHALIUM OBTUSIFOLIUMACTIVE MOIETY36XQ854NWW1
RUTA GRAVEOLENS FLOWERING TOPACTIVE MOIETYN94C2U587S1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
SOLANUM LYCOPERSICUMACTIVE MOIETY0243Q4990L1
STELLARIA MEDIAACTIVE MOIETY2H03479QVR1
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49726-03549726-035-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 328 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
METHYLPARABENMETHYLPARABENA2I8C7HI9TDROPS / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / DENTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRA-AMNIOTICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET / PERIODONTAL0.53 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, CHEWABLE / ORAL12 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, EXTENDED RELEASE / TRANSDERMAL0.85 mgExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / EPIDURAL1 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRATHECAL176 mgExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGRANULE, FOR SUSPENSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IENEMA / RECTAL0.44 %v/vExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / IONTOPHORESISADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION, EXTENDED RELEASE / ORAL40 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXOINTMENT / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, EMULSION / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / EPIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYSTEM / IONTOPHORESIS168.1 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INFILTRATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IDROPS / OPHTHALMICNAExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TAEROSOL, FOAM / TOPICAL0.16 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / PERIODONTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / IRRIGATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRADERMAL1 mgExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSHAMPOO / TOPICAL5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARYADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / VAGINAL22 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR27 mgExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR5.4 mgExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TELIXIR / ORAL800 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRASPINALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / ORAL11 mgExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / TOPICAL216 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM / BUCCAL0.09 mgExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / SUBCUTANEOUS0.16 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / INTRAMUSCULAR1 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / SUBARACHNOIDADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCONCENTRATE / ORAL12 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IOINTMENT / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAVENOUS78 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPASTE / DENTAL0.6 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRAVITREALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRASYNOVIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS78.36 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAVENOUS2.78 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / INTRAVENOUS0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INFILTRATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / TOPICAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL / VAGINAL20 mgExact identifier — unii candidate
174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c7d01297-8968-0c4f-e053-2a95a90a5b9414a18fc9-9384-4b33-958f-727df35933662021-07-23WarningsExact identifier
spl set id: 14a18fc9-9384-4b33-958f-727df3593366

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.